The single-use bioreactor market will increase at a CAGR of 21.6% from 2019 to 2025 to reach $3.37 billion by 2025. Single-use bioreactor utilizes disposable bag instead of reusable steel vessel used in conventional bioreactors. The use of single‑use bioreactor is influenced by the criticality of the step, fully automated technology, the value of the product produced, and the time taken for product development and production. Owing to the factors such as rapid adoption of disposable technology in pharmaceutical and biotechnology industry, cost effectiveness and lower downtime of single-use bioreactor, increase in government support for biopharmaceutical research, growing demand for biopharmaceuticals, and frequent launch of new products, this industry has witnessed a steady growth.
Furthermore, significant opportunities from emerging economies, demand for personalized medicine, and expected surge in biosimilar production in U.S. is expected to boost the growth of single-use bioreactor market in near future. For instance, according to PharmaManufacturing.com (e-magazine), ~$110 billion of biologics are expected to become off-patent by 2020. Hence, with the growing pressure to reduce the healthcare cost and regulatory clarity on biosimilar, the demand for biosimilars is likely to increase in coming years. Similarly, the increase in number of commercially available personalized medicine in the market from 5 in 2008 to 132 in number in 2016, is boosting the market with the similar trend.
Analysis of Market Segments
The global single-use bioreactor market is segmented by product (single-use bioreactor systems, media bags, filtration assemblies, and others), by molecule type (vaccines, monoclonal antibodies, stem cells, recombinant proteins, drugs, and others), type (stirred-tank, wave-induced, bubble-column, and others), cell type (mammalian, bacterial, yeast, and others), by application (bio production, research, and process development), usage (lab-scale, pilot-scale, large-scale), and end user (pharmaceutical & biotechnology company, contract research organizations research & academia), and geography.
Based on usage, lab-scale production is the most common setting in which single-use bioreactors are preferably used. Lab-scale production commanded the largest share of the global single-use bioreactor market in 2018, owing to simple operation, limited sterilization requirements, and reduced chances of cross-contamination.
Based on application, bio production commanded the largest market share of the global single-use bioreactor market. The high market share of this segment is due to growing demand for breakthrough therapies; increasing government funding; and growing research programs for biopharmaceutical production.
Click here to: Get Free Request Sample Copy of this report
Key Players
The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by the leading market participants in the industry over the past 5 years (2015-2018). The key players profiled in the global single-use bioreactor market research report are GE Healthcare, Merck Group, Danaher Corporation, Sartorius AG, Thermo Fisher Scientific Inc., Eppendorf AG, Applikon Biotechnology B.V., Solaris Biotechnology SRL, Cellexus Ltd, CESCO Bioengineering Co., Ltd., PBS Biotech, Inc., Pierre Guerin Technologies, Distek, Inc., Parker-Hannifin Corporation, Celltainer Biotech B.V., and Infors AG.
Future Outlook
Growing adoption of single-use technology since the past decade has been gaining traction at a fast pace and it is expected that most of the biopharmaceutical manufacturers will be having 100% fully disposables facility in operation in the coming years. In these facilities, the major device will be disposable bioreactors, with highest number of installations. Also, these bioreactors will be embedded with improved sensors and higher operational flexibility for multi-drug production within less time. Further, high capacity disposable bioreactors are expected to replace conventional bioreactors in large-scale manufacturing facilities.
Single-use Bioreactors Market Segmentation:
Single-use Bioreactors Products
Single-use Bioreactors Molecules
Single-use Bioreactors Types
Single-use Bioreactors for Cell Types
Single-use Bioreactors Applications
Single-use Bioreactors Usages
Single-use Bioreactors End users
Single-use Bioreactors Segmentation by Geography
Key players of the Single-use Bioreactors Market
Key questions answered in the report:
Pharmaceutical & biotechnology companies accounted for the largest share of the single-use bioreactor market, globally
Single-use bioreactor market favors both larger and local manufacturers that compete in multiple segments
Recent partnerships, acquisitions, and expansions have taken place in the global single-use bioreactor market
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Ecosystem
1.2. Currency & Limitation
1.2.1. Currency
1.2.2. Limitation
1.3. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. Executive Summary
4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Rapid Adoption of Disposable Technology in Pharmaceutical and Biotechnology Industry
4.2.2. Cost Effectiveness and Lower Downtime of Single-use Bioreactor
4.2.3. Increase in Government Support for Biopharmaceutical Research
4.2.4. Growing Demand for Biopharmaceuticals
4.2.5. Frequent Launch of New Products
4.3. Restraints
4.3.1. High Expenses Due to Recurrent Demand
4.3.2. Extractability and Leachability Issues Related to Disposable Components of Bioreactors
4.3.3. Stringent Regulatory Concerns associated with Single-use Bioreactor
4.4. Challenge
4.4.1. Limited Culturing Capacity
4.5. Opportunities
4.5.1. Significant Opportunities from Emerging Economies
4.5.2. Personalized Medicine to Offer New Growth Potential
4.5.3. Expected Surge in Biosimilar Production in U.S.
5. Single-use Bioreactor Market, by Product
5.1. Introduction
5.2. Single use Bioreactor systems
5.2.1. Upto 10L
5.2.2. 11L–100L
5.2.3. 101L–500L
5.2.4. 501L–1500L
5.2.5. Above 1500L
5.3. Media Bags
5.2.1. 2D Bags
5.2.2. 3D Bags
5.2.3. Other Bags
5.4. Filtration assemblies
5.5. Others
6. Single-use Bioreactor Market, by Molecule Type
6.1. Introduction
6.2. Vaccines
6.3. Monoclonal Antibodies
6.4. Stem Cells
6.5. Recombinant Proteins
6.6. Drugs
6.7. Others
7. Single-use Bioreactor Market, by Type
7.1. Introduction
7.2. Stirred-Tank
7.3. Wave-Induced
7.4. Bubble-Column
7.5. Others
8. Single-use Bioreactor Market, by Cell type
8.1. Introduction
8.2. Mammalian Cells
8.3. Bacterial Cells
8.4. Yeast Cells
8.5. Others
9. Single-use Bioreactor Market, by Application
9.1. Introduction
9.2. Bioproduction
9.3. Research and Development (R&D)
9.4. Process Development
10. Single-use Bioreactor Market, by Usage
10.1. Introduction
10.2. Lab-scale Production
10.3. Pilot-scale Production
10.4. Large-scale Production
11. Single-use Bioreactor Market, by End User
11.1. Introduction
11.2. Pharmaceutical & Biotechnology Companies
11.3. Contract Research Organizations (CROs)
11.4. Research and Academia
12. Single-use Bioreactor Market, by Geography
12.1. Introduction
12.2. North America
12.2.1. U.S.
12.2.2. Canada
12.3. Europe
12.3.1. Germany
12.3.2. France
12.3.3. U.K.
12.3.4. Italy
12.3.5. Spain
12.3.6. Rest of Europe
12.4. Asia-Pacific
12.4.1. Japan
12.4.2. China
12.4.3. India
12.4.4. Rest of Asia-Pacific
12.5. Rest of the World
12.5.1. Latin America
12.5.2. Middle East & Africa
13. Competitive Landscape
13.1. Competitive Benchmarking
13.1.1. By Usage
14. Company Profiles
14.1. GE Healthcare
14.2. Merck Group
14.3. Danaher Corporation
14.4. Sartorius AG
14.5. Thermo Fisher Scientific Inc.
14.6. Eppendorf AG
14.7. Applikon Biotechnology BV
14.8. Solaris Biotechnology SRL
14.9. Cellexus Ltd
14.10. CESCO Bioengineering Co., Ltd.
14.11. PBS Biotech, Inc.
14.12. Pierre Guerin Technologies
14.13. Distek, Inc.
14.14. Parker-Hannifin Corporation
14.15. Celltainer Biotech B.V.
14.16. Infors AG
15. Appendix
15.1. Questionnaire
15.2. Available Customization
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Sep-2019
Published Date: Oct-2018
Published Date: Dec-2022
Published Date: Jun-2019
